序号 |
标题 |
次数 |
作者 |
发布时间 |
75421 |
Cl-C6-PEG12-NHCO-C3-NHS,2727166-23-4烷基链 |
101 |
zyl |
2024-12-18 |
75422 |
PD-L1单抗修饰的尼洛替尼脂质体,LP-Nilotinib/αPDL1,αPDL1修饰的Nilotinib脂质体 |
121 |
axc |
2024-12-18 |
75423 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB CAS:2055042-69-6 |
85 |
WYQ |
2024-12-18 |
75424 |
Cl-C6-PEG9-NH2 hydrochloride-烷基链 |
74 |
zyl |
2024-12-18 |
75425 |
Fmoc-Val-Cit-PAB-OH CAS:159858-22-7 |
78 |
WYQ |
2024-12-18 |
75426 |
CAS:159857-80-4,MC-Val-Cit-PAB-OH ,MC-VAL-CIT-PAB中间体 |
74 |
kx |
2024-12-18 |
75427 |
Biotin-C6-amine,65953-56-2烷基链试剂 |
92 |
zyl |
2024-12-18 |
75428 |
鹿茸多肽脂质体水凝胶,Velvet,antler,peptides,liposome,hydrogel,VAP-Lip-Gel,脂质体纳米载体定制服务 |
100 |
axc |
2024-12-18 |
75429 |
NOTA-Bn-SCN-Aoc-BN(7-14)S-2-(4-异硫氰基苄基)-NOTA偶联BN(7-14) |
89 |
h |
2024-12-18 |
75430 |
CAS:2055048-57-0,Fmoc-PEG4-Ala-Ala-Asn-PAB ,芴甲氧羰基-四聚乙二醇-ALA-ALA ASN-PAB |
79 |
kx |
2024-12-18 |
75431 |
NH2-PEG3-C6-Cl,1261350-60-0 |
73 |
zyl |
2024-12-18 |
75432 |
MC-Val-Cit-PAB-PNP(CAS:159857-81-5) |
97 |
WYQ |
2024-12-18 |
75433 |
NOTA-HSA 大环配体NOTA偶联人血清白蛋白 |
73 |
h |
2024-12-18 |
75434 |
SPDP-Val-Cit-PAB-OH(N-琥珀酰亚胺基-3-(2-吡啶二硫)丙酸) |
60 |
WYQ |
2024-12-18 |
75435 |
鹿茸多肽脂质体,Velvet,antler,peptides,liposome,VAP-Lip,多功能载药脂质体定制服务 |
111 |
axc |
2024-12-18 |
75436 |
NOTA-西妥昔单抗-800CW NOTA-cetuximab-800CW |
71 |
h |
2024-12-18 |
75437 |
CAS:644981-35-1,Val-Cit-PAB-MMAE , ADC试剂 |
66 |
kx |
2024-12-18 |
75438 |
SPDP-Val-Cit-PAB-PNP,分子式:C33H39N7O9S2 |
85 |
WYQ |
2024-12-18 |
75439 |
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB(CAS:2055042-67-4) |
133 |
WYQ |
2024-12-18 |
75440 |
负载黄芩苷脂质体的纳米纤维膜,BCL-LPs/PVA-CS,NFs,载药脂质体定制服务 |
138 |
axc |
2024-12-18 |
75441 |
Auristatin E(CAS:160800-57-7),澳瑞他汀E |
91 |
WYQ |
2024-12-18 |
75442 |
Amino-PEG10-C6 氨基-聚乙二醇10-C6 |
79 |
zyl |
2024-12-18 |
75443 |
2762519-08-2,endo-BCN-PEG4-Val-Cit-PAB-MMAE,(1R,8S,9S)-双环[6.1.0]壬-四聚乙二醇-VAL-CIT-PAB-MMAE |
73 |
kx |
2024-12-18 |
75444 |
MMAE(CAS:474645-27-7),一甲基澳瑞他汀E,Monomethyl auristatin E |
175 |
WYQ |
2024-12-18 |
75445 |
m-PEG1-C11-SH,117559-62-3,甲基-一聚乙二醇-C11-巯基 |
74 |
zyl |
2024-12-18 |
75446 |
CAS:1703768-74-4,Vipivotide tetraxetan Linker , ADC试剂 |
73 |
kx |
2024-12-18 |
75447 |
Thalidomide-O-Cn-NH2,沙利度胺-烷基链-氨基 |
71 |
zyl |
2024-12-18 |
75448 |
Mal-amido-PEG8-val-gly-PAB-OH CAS号:2353409-52-4 |
82 |
WYQ |
2024-12-18 |
75449 |
cas:1042435-35-7,2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropoxy)ethoxy)ethoxy)ethyl acrylate,ADC定制 |
165 |
wyh |
2024-12-18 |
75450 |
Fmoc-PEG4-Ala-Ala-Asn-PAB,CAS号:2055048-57-0 |
85 |
WYQ |
2024-12-18 |
75451 |
CAS:1116086-09-9,Fmoc-Phe -Lys(Trt)-PAB-PNP , ADC试剂 |
76 |
kx |
2024-12-18 |
75452 |
DBCO-C12-amine 二苯并环辛炔-C12-胺 |
68 |
zyl |
2024-12-18 |
75453 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB,CAS号:2055042-69-6 |
105 |
WYQ |
2024-12-18 |
75454 |
C14-494 Lipid B4 CAS:2639634-80-1 |
74 |
zyl |
2024-12-18 |
75455 |
NOTA-ZnPc缀合物 水溶性磺化锌酞菁缀合1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA) |
67 |
h |
2024-12-18 |
75456 |
cas:663598-66-1,NO2-SPP-sulfo,ADC定制 |
71 |
wyh |
2024-12-18 |
75457 |
Val-Cit-PAB-MMAE(CAS:644981-35-1) |
116 |
WYQ |
2024-12-18 |
75458 |
NOTA-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-nhch 2ch3 NOTA-atbbn |
81 |
h |
2024-12-18 |
75459 |
MAL-tetra-EG-OPFP,ADC定制 |
106 |
kx |
2024-12-18 |
75460 |
MC-Val-Cit-PAB-MMAE(CAS:646502-53-6) |
93 |
WYQ |
2024-12-18 |
75461 |
Fmoc-Val-Cit-PAB-MMAE(CAS:1350456-56-2) |
69 |
WYQ |
2024-12-18 |
75462 |
NOTA-VHH-Za 融合蛋白VHH-Zag偶联双功能螯合剂NOTA |
76 |
h |
2024-12-18 |
75463 |
Py-ds-Prp-OSu, ADC试剂 |
130 |
kx |
2024-12-18 |
75464 |
MMA-NOTA 马来酰亚胺单酰胺缀合1,4,7-三氮杂壬烷-1,4,7-三酰基)三乙酸 |
95 |
h |
2024-12-18 |
75465 |
辣根过氧化氢酶-棕榈酸 HRP-C16 palmitic acid |
81 |
zyl |
2024-12-18 |